Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- Check3 days agoChange DetectedVersion bumped to v3.0.2; previous v3.0.1 tag and the 'Back to Top' element were removed.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check17 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as specific drug information related to Quizartinib and resources for Acute Myeloid Leukemia. Notably, several previous entries have been removed, particularly related to genetic diseases and certain locations.SummaryDifference11%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.5%
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.5%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.